Curebase

company

About

Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$40M
Industries
Clinical Trials,Health Care,Software
Founded date
Jan 1, 2017
Number Of Employee
101 - 250
Operating Status
Active

Curebase builds a digital clinical trial assistant that would alter how medical providers discover, activate, and administer clinical trials for their patients. It aims to run clinical trials faster and cheaper than anyone else via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics.

The company was established in 2017 and is based in San Francisco, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$40M
Curebase has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on May 5, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 5, 2022 Series B $40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Curebase is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series B